inositol has been researched along with Basal Ganglia Diseases in 3 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Myoinositol was elevated in the patient with abnormally high serum sodium, and decreased in the hemolytic-uremic syndrome." | 1.30 | 1H MR spectroscopy of the basal ganglia in childhood: a semiquantitative analysis. ( Berry, GT; Bilaniuk, LT; Gibson, J; Haselgrove, JC; Hunter, JV; Kaplan, BS; Kaplan, P; Lam, WW; Wang, ZJ; Zhao, H; Zimmermann, RA, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tonduti, D | 1 |
| Vanderver, A | 1 |
| Berardinelli, A | 1 |
| Schmidt, JL | 1 |
| Collins, CD | 1 |
| Novara, F | 1 |
| Genni, AD | 1 |
| Mita, A | 1 |
| Triulzi, F | 1 |
| Brunstrom-Hernandez, JE | 1 |
| Zuffardi, O | 1 |
| Balottin, U | 1 |
| Orcesi, S | 1 |
| Yamasue, H | 1 |
| Fukui, T | 1 |
| Fukuda, R | 1 |
| Kasai, K | 1 |
| Iwanami, A | 1 |
| Kato, N | 1 |
| Kato, T | 1 |
| Lam, WW | 1 |
| Wang, ZJ | 1 |
| Zhao, H | 1 |
| Berry, GT | 1 |
| Kaplan, P | 1 |
| Gibson, J | 1 |
| Kaplan, BS | 1 |
| Bilaniuk, LT | 1 |
| Hunter, JV | 1 |
| Haselgrove, JC | 1 |
| Zimmermann, RA | 1 |
3 other studies available for inositol and Basal Ganglia Diseases
| Article | Year |
|---|---|
MCT8 deficiency: extrapyramidal symptoms and delayed myelination as prominent features.
Topics: Aspartic Acid; Basal Ganglia Diseases; Brain; Child, Preschool; Choline; Chromosomes, Human, X; Codo | 2013 |
Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Aspartic Acid; Basal Ganglia Diseases; Choline; Chronic Disease; Creati | 2003 |
1H MR spectroscopy of the basal ganglia in childhood: a semiquantitative analysis.
Topics: Adolescent; Adult; Aspartic Acid; Basal Ganglia; Basal Ganglia Diseases; Brain Diseases, Metabolic; | 1998 |